Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.
Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.
Physician’s Weekly interviewed dermatologist Geeta Yadav, MD, for her perspective on the March Journal of Drugs in Dermatology study, “Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema.”…
Topical Metformin versus Kligman’s Formula for Melasma, a Split-Face JDD Study This is a must-read article from JDD a head-to-head split-face study asks whether topical metformin can be an effective,…
Extended Pembrolizumab Duration Tied to Lower Mortality in Stage III and IV Melanoma: JDD Report Could extending pembrolizumab improve survival? This JDD is a must read. A new retrospective analysis…
New JDD Study Introduces Objective Method for Measuring Periorbital Dynamic Lines For dermatology teams focused on antiaging care, this article from the JDD is a must read. Dermatologists and clinical…
ALA PDT for Facial isSCC Shows Complete Histological Clearance in Early Trial Have you read this article from JDD? A study reports striking short term outcomes after two sessions of…
Must-read JDD Letter to the Editor: Pooled analysis finds no significant association between benzoyl peroxide use for acne and risk of hematologic or internal malignancies This JDD “Letter to the…